| Primary information |
|---|
| sequence ID | Seq_4188 |
| Peptide sequence | KGNSGEPGAPGSKGDTGAKGEPGPVG |
| CancerPDF_ID | CancerPDF_ID3415, CancerPDF_ID5595, CancerPDF_ID10919, |
| PMID | 27186406,24982608,21805675 |
| Protein Name | Collagen type a1,Collagen alpha-1(I) chain,Collagen alpha-1(I) chain |
| UniprotKB Entry Name | CO4A1_HUMAN,CO1A1_HUMAN,CO1A1_HUMAN |
| Fluid | Urine,Urine,Urine |
| M/Z | NA,NA,2356.0992 |
| Charge | NA,NA,NA |
| Mass (in Da) | NA,NA,NA |
| fdr | NA,NA,NA |
| Profiling Technique | LC-MS,Nano-LC-MS,MALDI-TOF |
| Peptide Identification technique | SRM (Selective reaction Measurement),MS/MS,MALDI-TOF-MS |
| Quantification Technique | NA,NA,NA |
| Labelled/Label Free | Labelled,Label Free,Label Free |
| FDR | NA,0.01,1 |
| CancerPDF_ID | CancerPDF_ID3415, CancerPDF_ID5595, CancerPDF_ID10919, |
| p-Value | less than 0.001,NA,NA |
| Software | NA,"GPM search engine, MASCOT",NA |
| Length | 26,26,26 |
| Cancer Type | CRLM( Colorectal liver metastses),Ovarian cancer,Muscle-invasive bladder cancer |
| Database | NA,IPI 3.71 Human Database ,SwissProt Database |
| Modification | "Hydroxylation at 6,21 residue",NA,"Oxidation: 7, 10, 22" |
| Number of Patients | 100 patients,6 Ovarian cancer patients and 6 normal individuals,751 bladder cancer and 127 control |
| Regulation | NA,Uniquely present in case of urine of ovarian cancer patients,Differentially expressed between cancer vs normal samples |
| Validation | Cross-validation,NA,Mann-Whitney tests and areas under receiver-operator characteristic |
| Sensitivity | 0.85,NA,NA |
| Specificity | 0.84,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | NA |
| IEDB | |
| Primary information |
|---|
| sequence ID | Seq_4189 |
| Peptide sequence | KGNSGEPGApGSKGDTGAKGEPGpVG |
| CancerPDF_ID | CancerPDF_ID3737, |
| PMID | 27026199 |
| Protein Name | Collagen alpha-1(I) chain |
| UniprotKB Entry Name | CO1A1_HUMAN |
| Fluid | Urine |
| fdr | 2339.1 |
| Profiling Technique | "CE-MS, Micro-TOF-MS" |
| Peptide Identification technique | MS-MS |
| Labelled/Label Free | Label Free |
| CancerPDF_ID | CancerPDF_ID3737, |
| p-Value | less than 0.05 |
| Software | Proteome Discoverer 1.2 |
| Length | 26 |
| Cancer Type | Bladder cancer |
| Database | Uniprot Human non-redundant Database |
| Modification | p:Hydroxy-Proline |
| Number of Patients | 425 for training(109 patients with Recurrent UBC cases and 316 negative for recurrence controls) and 211 for validation (55 UBC recurrent cases and 156 recurrent controls) |
| Regulation | Differentially expressed between recurrence of UBC vs recurrence control |
| Validation | Independent Validation |
| Sensitivity | For testing dataset 88% |
| Specificity | For testing dataset 51% |
| Accuracy | NA |
| Peptide Atlas | NA |
| IEDB | NA |
| Primary information |
|---|
| sequence ID | Seq_4190 |
| Peptide sequence | KGNSGEpGAPGSKGDTGAKGEpGpVG |
| CancerPDF_ID | CancerPDF_ID3742, |
| PMID | 27026199 |
| Protein Name | Collagen alpha-1(I) chain |
| UniprotKB Entry Name | CO1A1_HUMAN |
| Fluid | Urine |
| fdr | 2355.09 |
| Profiling Technique | "CE-MS, Micro-TOF-MS" |
| Peptide Identification technique | MS-MS |
| Labelled/Label Free | Label Free |
| CancerPDF_ID | CancerPDF_ID3742, |
| p-Value | less than 0.01 |
| Software | Proteome Discoverer 1.2 |
| Length | 26 |
| Cancer Type | Bladder cancer |
| Database | Uniprot Human non-redundant Database |
| Modification | p:Hydroxy-Proline |
| Number of Patients | 425 for training(109 patients with Recurrent UBC cases and 316 negative for recurrence controls) and 211 for validation (55 UBC recurrent cases and 156 recurrent controls) |
| Regulation | Differentially expressed between recurrence of UBC vs recurrence control |
| Validation | Independent Validation |
| Sensitivity | For testing dataset 88% |
| Specificity | For testing dataset 51% |
| Accuracy | NA |
| Peptide Atlas | NA |
| IEDB | NA |
| Primary information |
|---|
| sequence ID | Seq_4191 |
| Peptide sequence | KGNSGEpGApGSKGDTGAKGEpGpVG |
| CancerPDF_ID | CancerPDF_ID3744, |
| PMID | 27026199 |
| Protein Name | Collagen alpha-1(I) chain |
| UniprotKB Entry Name | CO1A1_HUMAN |
| Fluid | Urine |
| fdr | 2371.09 |
| Profiling Technique | "CE-MS, Micro-TOF-MS" |
| Peptide Identification technique | MS-MS |
| Labelled/Label Free | Label Free |
| CancerPDF_ID | CancerPDF_ID3744, |
| p-Value | less than 0.01 |
| Software | Proteome Discoverer 1.2 |
| Length | 26 |
| Cancer Type | Bladder cancer |
| Database | Uniprot Human non-redundant Database |
| Modification | p:Hydroxy-Proline |
| Number of Patients | 425 for training(109 patients with Recurrent UBC cases and 316 negative for recurrence controls) and 211 for validation (55 UBC recurrent cases and 156 recurrent controls) |
| Regulation | Differentially expressed between recurrence of UBC vs recurrence control |
| Validation | Independent Validation |
| Sensitivity | For testing dataset 88% |
| Specificity | For testing dataset 51% |
| Accuracy | NA |
| Peptide Atlas | NA |
| IEDB | NA |